Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53

Details for Australian Patent Application No. 2004224488 (hide)

Owner Aprea AB

Inventors Selivanova, Galina; Bao, Wenije; Issaeva, Natalia; Stromblad, Staffan

Agent Davies Collison Cave

Pub. Number AU-B-2004224488

PCT Pub. Number WO2004/084893

Priority 60/456,525 24.03.03 US; 0300812-5 24.03.03 SE

Filing date 24 March 2004

Wipo publication date 7 October 2004

Acceptance publication date 10 September 2009

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/084893 Priority application(s): WO2004/084893

10 September 2009 Application Accepted

  Published as AU-B-2004224488

14 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224492-Method of powdering nonsugar component and powdering base

2004224487-Composition comprising iscom particles and live micro-organisms